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A progressive increase in MECP2 protein levels is a
crucial and precisely regulated event during neurode-
velopment, but the underlying mechanism is unclear.
We report thatMECP2 is regulatedpost-transcription-
ally during in vitro differentiation of human embryonic
stem cells (hESCs) into cortical neurons. Using re-
porters to identify functional RNA sequences in
the MECP2 30 UTR and genetic manipulations to
explore the role of interacting factors on endogenous
MECP2, we discover combinatorial mechanisms that
regulate RNA stability and translation. The RNA-bind-
ingproteinPUM1andpluripotent-specificmicroRNAs
destabilize the long MECP2 30 UTR in hESCs. Hence,
the 30 UTR appears to lengthen during differentiation
as the long isoformbecomesstable in neurons.Mean-
while, translation of MECP2 is repressed by TIA1 in
hESCs until HuC predominates in neurons, resulting
in a switch to translational enhancement. Ultimately,
30 UTR-directed translational fine-tuning differentially
modulates MECP2 protein in the two cell types to
levels appropriate for normal neurodevelopment.
INTRODUCTION
Methyl CpG-binding protein 2 (MECP2) modulates global
transcription and translation that is crucial for normal brain devel-
opment and physiology (Li et al., 2013; Lyst and Bird, 2015).
Heterozygous mutations of the MECP2 gene cause Rett syn-
drome, andmild overexpression in mice or duplications and trip-
lications in the MECP2 locus in humans lead to neurological
impairment (Chahrour and Zoghbi, 2007). These studies suggest
that MECP2 protein levels must be tightly regulated during neu-
rodevelopment in order to maintain proper regulation of a large
number of genes.720 Cell Reports 17, 720–734, October 11, 2016 ª 2016 The Author(s
This is an open access article under the CC BY-NC-ND license (http://MECP2 protein levels correlate poorly with mRNA levels in
different tissues, suggesting important roles for post-transcrip-
tional mechanisms (Pelka et al., 2005; Shahbazian et al., 2002).
Although specific microRNAs (miRNAs) are known to repress
MECP2 in the fetal brain (Han et al., 2013) and primary
cortical neurons (Klein et al., 2007), the pathways that post-tran-
scriptionally downregulate MECP2 in pluripotent stem cells and
upregulate in neurons are unknown. Moreover, the physiological
significance of premature MECP2 protein overexpression in
pluripotent cells is untested.MECP2mRNA is subject to alterna-
tive splicing to generate E1 and E2 transcript isoforms that differ
in the presence or absence of exon 2 (Kriaucionis and Bird,
2004). Importantly, theseMECP2 isoforms are alternatively poly-
adenylated (APA), producing four different 3’ UTR lengths,
including the unusually long 8.6-kb 3’ UTR found in neurons
(Singh et al., 2008). These distinct transcripts are potential plat-
forms for differential post-transcriptional regulation.
RNA-binding proteins (RBPs) regulate diverse aspects of RNA
biology, including stability and/or translation efficiency (Parker
and Sheth, 2007). For example, Pumilio1 (PUM1) interacts with
PUM1-binding elements (PBEs) in the 30 UTR of target mRNAs,
causing destabilization by recruiting deadenylase complexes
(Goldstrohm et al., 2007; Van Etten et al., 2012). PUM1 also
can facilitate miRNA-dependent silencing by inducing confor-
mational changes in the 30 UTR secondary structure of target
genes to make miRNA seed sequences near PBE sites more
accessible (Kedde et al., 2010; Miles et al., 2012). RBPs can
control the translational efficiency of transcripts and their
engagement with polysomes. This includes TIA1, which medi-
ates translational silencing of transcripts containing adenine/uri-
dine (AU)- or uridine (U)-rich sequence elements. Similar RNA
targets are bound by the neuron-specific ELAVL-3/HuC protein.
HuC is a member of a family of RBPs whose functions are intri-
cately implicated in neuronal differentiation, maturation, and
maintenance (Ince-Dunn et al., 2012; Simone and Keene, 2013).
Here we demonstrate that post-transcriptional regulatory
mechanisms have a major role in determining MECP2 protein
levels in the first steps of human neurodevelopment, as defined).
creativecommons.org/licenses/by-nc-nd/4.0/).
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using a human embryonic stem cell (hESC) differentiation model
that enriches for the generation of cortical neurons. As differentia-
tion proceeds,MECP2 transcriptswith the long30 UTR (8.6 kb) are
stabilized and MECP2 protein accumulates in neurons. We show
that premature overexpression of high MECP2 protein levels in
hESCs results in reduced stem cell proliferation. To safeguard
against such a detrimental effect, the long isoform is actively tran-
scribed inhESCsbut is rapidlydegraded,whereas thestable short
isoform is translationally silenced. We characterize a sequence
element present only in the long isoform that is recognized by
PUM1, which acts together with the miRNAs hsa-miR-200a and
hsa-miR-302c to destabilize the longMECP2 transcript in hESCs.
We also found that a U-rich sequence element present in the 30
UTR of both isoforms is responsible for negative and positive
translational regulation, where it is recognized by TIA1 in hESCs
for translation repression andbyHuC for translation enhancement
in neurons. Our study shows howMECP2 protein levels are differ-
entially regulated in hESCs and neurons, and it uncovers the
combinatorial circuitry ofmultiple RBPs andmiRNAs that regulate
MEPC2 protein levels during neurodevelopment.
RESULTS
Recapitulation of Human Forebrain Development
In Vitro
To investigate the post-transcriptional mechanisms of MECP2
gene regulation during neurodevelopment, we established a pro-
tocol for the efficient generation of cortical neurons from human
pluripotent stem cells. Cortical neurons arise in the dorsal/ante-
rior domain of the developing brain (Hansen et al., 2011), and we
hypothesized that this regional identity could be promoted by a
dual-SMAD inhibition method coupled with inhibition of WNT
signaling (Maroof et al., 2013; Nicoleau et al., 2013). The dual-
SMAD inhibition resulted in a highly pure population of cells
that stained for the neuronal progenitor markers SOX1, SOX2,
NESTIN, and PAX6, but only a small fraction of cells expressed
the anterior markers FOXG1 andOTX2 (Figures S1A–S1C). How-
ever, treatment of H9 hESCs with the WNT inhibitor XAV939
(XAV) over 12 days of neural induction remarkably enhanced
the expression of anterior neural markers FOXG1 and OTX2,
and it reduced the expression of midbrain and hindbrain markers
EN1 and HOXA2 (Figures 1A, 1B, and S1D).Figure 1. Fate Patterning of NPCs toward Anterior Neuronal Cells
(A) Schematic shows anterior neural cell differentiation by treatment with XAV ove
(B) qRT-PCR shows increased expression of anterior markers (FOXG1 and OTX2
after XAV939 treatment of H9 hESCs (D0–4, D0–8, and D0–12).
(C and D) Immunofluorescence images and quantification of positive cells are sh
(E) Immunofluorescence images after 9 weeks of neuronal differentiation (two bo
CTIP2, or SATB2. Scale bars, 100 mm.
(F) Frequency of CTIP2+ or SATB2+ neurons is shown.
(G) Colocalization of PSD95 and Synapsin-1 along MAP2+ neuronal processes is
(H) qRT-PCR shows the small increase in MECP2 mRNA steady state from hESC
(I) qRT-PCR of newly transcribed mRNAs from MECP2 and controls ACTB, GAP
(J) Western blot shows increased MECP2 protein levels in neurons compared to
(K) Western blot shows hESC overexpressing the different MEPC2 gene isoform
(L) Alkaline-phosphatase staining of hESC overexpressing MEPC2 isoforms is sh
(M) Proliferation assay with daily cell number counts. Cells were passed on days 1
ANOVA, Bonferroni post-test). See also Figure S1.
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for anterior specification of neural progenitor cells (NPCs), we
dissected the 12 days into three stages of 4 days each and
applied XAV as described in Figure 1A. The qRT-PCR revealed
that treatment with XAV during the first 4 days showed effects
comparable to the 12-day treatment (Figure 1B), in contrast
with treatment over days 4–8 or days 8–12. Treatment with
XAV during the first 4 days increased FOXG1+ and OTX2+ cells
and decreased EN1+ cells (Figures 1C [i–vi], 1D, S1E, and
S1F). The Forse-1 marker of embryonic forebrain predominantly
detected cells in the XAV-treated group (Figure 1C [vii and viii]).
Interestingly, SOX1+ cells increased with XAV treatment, sug-
gesting that WNT inhibition can increase the efficiency of neural
induction, possibly by suppressing commitment to the neural
crest lineage (Menendez et al., 2011) (Figures 1C [ix and x] and
1D). Finally, we found no difference in Ki67+ proliferating cells
(Figures 1C [ix and x] and 1D). The robustness of this method
was confirmed in a human induced pluripotent stem cell (iPSC)
line previously generated in our lab (Cheung et al., 2011) (Figures
S1E and S1F). In conclusion, our data demonstrate that WNT
inhibition during the initial 4 days of dual-SMAD differentiation
promotes the specification of NPCs with anterior fate.
To examine whether hESC-derived NPCs produced by this
protocol generate cortical neurons, we further differentiated
these cells using a previously reported neuronal differentiation
method (Brennand et al., 2011). After 2 weeks, small clumps of
PAX6+ and cortical progenitor marker TBR2+ cells were found
(Figure S1G). Cells migrating out of the clumps were also
Ki67 and DCX2+ (Figure S1H), consistent with cortical progen-
itor molecular identity. After 9 weeks, MAP2+ neuronal cells were
co-labeled with markers for mature cortical neurons, including
the cortical layer markers CTIP2 and SATB2 (Figures 1E and
1F). PSD95 and SYNAPSIN1 colocalized along MAP2+ neuronal
processes, indicating the formation of mature synaptic connec-
tions (Figure 1G). Collectively, our data suggest that dual-SMAD
and WNT inhibition produces cortical progenitors that differen-
tiate into mature cortical neurons.
MECP2 Is Post-transcriptionally Regulated during
Human Neurodevelopment
We observed a significant discrepancy between the levels of
MECP2 transcript and protein over the course of neuronalr 12 days in three stages of 4 days each. Dorsomorphin + SB431542 (DM+SB).
) and decreasing expression of midbrain markers (EN1) and hindbrain (HOXA2)
own. Scale bar, 100 mm.
ttom layers). Most cells were positive for the cortical neuron markers MAP2,
shown. Scale bar, 10 mm.
s to NPCs and neurons (n = 3).
DH, OCT4, and BDNF using the Click-It assay (n = 3) is shown.
NPCs and hESCs (n = 3).
s at levels comparable to hESC-derived neurons.
own.
, 7, and 14 (*p < 0.05, **p < 0.01, and ****p < 0.0001; for Figure 1M *p < 0.0001;
differentiation. MECP2 transcripts were detected in H9 hESCs
and NPCs by qRT-PCR using a primer set designed to detect
all MECP2 transcript isoforms, and the steady-state levels
increased by 2- to 3-fold in the hESC-derived neurons (Fig-
ure 1H). To investigate whether the modest increase in the total
transcript levels is caused by increased transcription of MECP2
in neurons, we measured the levels of MECP2 nascent mRNAs
(newly transcribed) in hESCs and neurons. Cells were pulse-
labeled with 5-ethynyl uridine (EU) for 30 min and total RNA
was extracted. Newly synthesized EU-RNAs were separated
from the total RNA by biotinylation of EU using the click chemis-
try method (Jao and Salic, 2008), followed by pull-down of bio-
tinylated EU-RNAs using streptavidin magnetic beads.
Using the captured RNA as a template for cDNA synthesis and
qRT-PCR, we determined that there was no significant change in
MECP2 transcription efficiency between hESCs and neurons
(Figure 1I). The controls indicated that ACTB may have been
more actively transcribed in neurons but GAPDH transcription
levels were equivalent between hESCs and neurons. As ex-
pected, OCT4 was highly transcribed in hESCs while BDNF
was highly transcribed in neurons. These results suggest that
the increase in steady-state levels of MECP2 transcripts is
caused by differential mRNA stabilization in hESCs and neurons.
Interestingly, despite the abundance of MECP2 transcripts in
hESCs and NPCs, we detected low levels of MECP2 protein
levels by western blot in both cell types in contrast to the high
levels present in neurons (Figure 1J). Taken together, these re-
sults show thatMECP2 is actively transcribed throughout human
neurodevelopment, but protein levels are regulated by post-tran-
scriptional mechanisms.
Premature MECP2 Overexpression in hESCs Affects
Stem Cell Proliferation
To evaluate potential consequences of premature overexpres-
sion of MECP2 in H9 hESCs, we overexpressed both MECP2
gene isoforms (E1 and E2). We used lentiviral vectors lacking
the MECP2 UTRs, and we titrated infections to express the
same physiological levels of MECP2 protein found in neurons
(Figure 1K). Interestingly, we observed smaller Alkaline Phos-
phatase+ colony size of MECP2-overexpressing hESCs, sug-
gestive of a deficit in cell proliferation (Figure 1L). To quantify
the proliferation deficit, we counted the cell number over a period
of 19 days and three cell passages. Figure 1M shows that hESCs
overexpressing MECP2-E1 had significantly reduced cell
numbers of 2-fold per passage compared to untransduced
wild-type (WT) or GFP control cells. Together these data indicate
that excess MECP2 protein is detrimental to hESCs. We there-
fore focused on defining mechanisms ofMECP2 post-transcrip-
tional regulation in hESCs and neurons.
MECP2 Transcripts with the Long 30 UTR Are
Differentially Stabilized in hESCs and Neurons
To gain insight into the functional roles of the MECP2 30 UTR in
hESCs and neurons, we first characterized the levels of each
of the four APA transcript variants (Figure 2A, arrowheads) during
human neurodevelopment. To this end, we re-analyzed RNA
sequencing (RNA-seq) data from the CORTECON database,
which measured the changes in steady state of mRNAs at mul-tiple points during the course of neuronal differentiation from
hESCs (van de Leemput et al., 2014). We observed robust levels
of the short (0.1 kb) and the long (8.6 kb) isoforms of MECP2
mRNAs in hESCs and neurons, in contrast to negligible amounts
of the other two intermediate isoforms (Figure 2B). While the
short isoform levels were consistently maintained during neuro-
development, the steady-state levels of the long isoform pro-
gressively increased (Figure 2B). We validated the CORTECON
data by qRT-PCR using our hESC, NPC, and neuron RNA sam-
ples by measuring the levels of total and long 30 UTR MECP2
transcripts, using primer sets against exons 3 and 4 (present in
all isoforms, Figure 2A, red line) and a region immediately up-
stream of the 8.6-kb polyadenylation (PA) site, respectively (Fig-
ure 2A, blue line). In agreement with the CORTECONdataset, the
qRT-PCR showed an increase in the total levels ofMECP2 tran-
scripts of3-fold, while the steady-state level of the long isoform
increased 8-fold in neurons (Figure 2C), raising the possibility
that the stability of the long isoformmay be post-transcriptionally
regulated (Figure S2).
To determine the relative stability of MECP2 transcripts in
hESCs and neurons, we measured the half-life of the total and
long MECP2 transcripts. In hESCs the half-life of total MECP2
was3 hr, whereas the longMECP2 transcript isoformwas rela-
tively unstable with a half-life of less than 1 hr (Figure 2D). In
contrast, in neurons the degradation of the long isoform was
barely detectable even after 5 hr, suggesting a dramatic stabiliza-
tion of the transcript. As expected, the unstable MYC transcript
used as a control had a short half-life of less than 1 hr in both
cell types. Together with the transcription efficiency assay (Fig-
ure 1I), these data suggest that both long and shortMECP2 tran-
scripts are produced in hESCs, but the long transcript is rapidly
degradedand therefore accumulates to lower steady-state levels
than the short isoform. As neuronal differentiation progresses,
the long isoformbecomesdramaticallymore stable and accumu-
lates in neurons to levels equivalent to the short isoform.
The 30 UTR Directs Post-transcriptional Regulation of
MECP2 in hESCs and Neurons
Since MECP2 transcripts contain an unusually long 30 UTR that
is retained preferentially in neurons, we reasoned that it may
contain sequence elements with important regulatory functions.
To identify functionally significant regions, we cloned fragments
of theMECP2 30 UTR in luciferase reporter plasmids for transfec-
tion into hESCs and neurons, and we measured mRNA levels
and luciferase activity (Figure 3A). The minimal regions with the
largest differences between hESCs and neurons were the frag-
ments corresponding to nucleotides 4,265–5,677 and 1–149 of
the 8.6-kb 30 UTR. In comparison to the control plasmid
(pLUC-GAPDH), reporter pLUC-4,265–5,677 had reduced re-
porter mRNA, suggesting that it contains sequence elements
capable of mRNA destabilization and, consequently, lower lucif-
erase activity in hESCs. Importantly, reporter pLUC-1–149 lucif-
erase activity was reduced in hESCs and enhanced in neurons,
but the reporter mRNA levels were unchanged, suggesting that
this fragment contains sequence elements capable of regulating
translation.
Given the high sequence conservation throughout the 30 UTR
among other species, it is not surprising that all fragmentsCell Reports 17, 720–734, October 11, 2016 723
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Figure 2. MECP2 Transcripts Are Differentially Stabilized during Neurodevelopment
(A) Schematic representation of the long 30 UTR ofMECP2mRNA. Arrowheads indicate PA sites. Red and blue lines indicate regions targeted for qRT-PCR of the
total or long MECP2 transcripts, respectively.
(B) Quantification of the four APA isoforms ofMECP2mRNA produced during neurodevelopment using RNA-seq data from the CORTECON Database is shown.
(C) qRT-PCR confirms changes in MECP2 transcript levels (total and long) during neurodevelopment (n = 3).
(D) Effect of neuronal differentiation on the half-life ofMECP2 transcripts determined by qRT-PCR (n = 3). Quantification ofMYCwas used as a control. Error bars,
SEM; *p < 0.05 and ***p < 0.001 (ANOVA, Bonferroni post-test). See also Figure S2.had some reduction in luciferase reporter activity in hESCs.
This includes the pLUC-1–4,508 fragment that contains the
known miRNA site functioning in fetal brain (Han et al., 2013),
which had a modest effect on post-transcriptional regulation
in our experimental system. Taken together, these results
show that the MECP2 30 UTR contains previously uncharacter-
ized sequence elements capable of regulating mRNA stabiliza-
tion and translation in hESCs and neurons, with the most differ-
entially active regions being located in fragments 4,265–5,677
and 1–149.
Identification of Candidate AU-Rich Sequences and
RBPs
Stretches of AU-rich sequences are known to be targeted by
RBPs and regulate mRNA stability and translation in cells724 Cell Reports 17, 720–734, October 11, 2016including hESCs (Yokoshi et al., 2014). Sequence examination
identified long, highly conserved, AU-rich sequences in regions
located between 4,265–5,677 and 1–149. To directly evaluate
the interaction of these two conserved regions with RBPs in
hESCs, we performed RNA electrophoretic mobility shift assays
(REMSAs). Shifted bands were produced in the presence of
hESC protein extract and competed by excess specific unla-
beled fragments, but not non-specific tRNA and reverse-strand
competitor fragments (Figure 3B). These results demonstrate
that the two candidate regions interact with RBPs present in
hESCs.
Affinity purification mass spectrometry assay was performed
to identify RBPs from hESCs and neurons that interact with the
MECP2 30 UTR fragments. A number of proteins were associated
with the two fragments (Table S1). However, themajority of these
AB
Figure 3. The 30 UTR of MECP2 Contains
Sequence Elements Capable of Post-tran-
scriptional Regulation
(A) Schematic representation of reporter plasmids
used for luciferase assays. Numbers represent the
nucleotide position at the beginning and end of
each 30 UTR fragment. Luciferase activity and
mRNA levels are plotted relative to control pLUC-
GAPDH (n = 10–24). RLU, relative light units. Error
bars, SEM; *p < 0.05, **p < 0.01, and ****p < 0.001;
ns, not significant (ANOVA, Bonferroni post-test).
(B) REMSA using RNA probes in the presence of
hESC protein extracts. See also Figure S3.RBP candidates have redundant consensus-binding sites that
are widely distributed throughout theMECP2 30 UTR (Figure S3),
and therefore, they would be expected to have widespread ef-
fects on multiple regions. We narrowed the search for candidate
RBPs to those with consensus sequences in the most important
regions determined by reporter assays. In fragment 5,369–5,541,
PUM1 was the only RBP candidate with potentially high binding
specificity known to participate in mRNA destabilization. In frag-
ment 1–149, the only RBPs with known functions related to
translational regulation that shared the same consensus-binding
site were TIA1 and HuC (ELAVL3).
PUM1 Destabilizes the Long Isoform of MECP2
Transcripts in hESCs and NPCs via a Conserved PBE
Further investigation of the MECP2 30 UTR sequence revealed
two putative PBEs (50-UGUANAUA/U-30) (Van Etten et al.,
2012) at positions 1,103–1,110 (PBE1) and 5,489–5,496
(PBE2). The latter site was located in the probe used for both
the RNA gel shift and affinity purification assays (Figure 4A).
Sequence alignment (Figure S4A) showed that PBE1 was
moderately conserved, while PBE2 was highly conserved and
present in all species analyzed. To rapidly test whether these
elements confer differential post-transcriptional regulation viaCell RPUM1 interaction, we co-transfected the
luciferase reporter vectors with plasmids
for PUM1 or GFP overexpression in
293T cells. PUM1 overexpression signifi-
cantly reduced luciferase activity of the
two reporters containing PBE2, but not
PBE1 (Figure 4B). In contrast, knockdown
of PUM1 using two independent small
interfering RNAs (siRNAs) increased re-
porter activity of the two PBE2-containing
plasmids (Figure S4B). Moreover, the
half-life of the pLUC-4,265–5,677 re-
porter mRNA (containing PBE2) in 293T
was reduced to 3 hr by PUM1 overex-
pression compared to >6 hr in the GFP
control. The half-life was reciprocally
increased by knockdown of PUM1 by
both siRNAs in comparison to the control
knockdown (Figure 4C). In contrast,
PUM2 had no effect in the reporter
studies (Figure S4C). These resultsdemonstrate that PUM1 acts in trans to destabilize reporter
transcripts containing the conserved PBE from the 30 UTR of
MECP2.
We next confirmed the importance of the active sequences in
PBE2 by site-directed mutagenesis. We generated two mutant
reporters containing either a deletion of PBE2 (PBE del) or a
change of the first half of the sequence element (PBE mt) (Fig-
ure 4D). Indeed, both deletion and mutation of PBE2 abolished
the inhibitory effects of PUM1 overexpression in 293T cells and
reversed the increase in reporter activity observed after PUM1
knockdown (Figure 4D). Importantly, we found that deletion
or mutation of PBE2 also significantly increased reporter
activity in hESCs (Figure 4E). Notably, reporter activity did not
completely recover to control levels, suggesting that additional
functional sequences outside PBE2 also are recognized in
hESCs.
Because MECP2 transcripts are also post-transcriptionally
regulated in NPCs, we studied the effects of PUM1 knockdown
in these cells. Indeed, reduction of PUM1 levels by both small
hairpin RNAs (shRNAs) induced accumulation of the total frac-
tion of MECP2 transcript (Figure S4D). Western blot analyses
showed that PUM1, but not the ACTB control, was reduced in
the knockdowns and that MECP2 protein levels were slightlyeports 17, 720–734, October 11, 2016 725
increased in NPCs, as expected (Figure S4E). Accordingly,
knockdown of PUM1 in neurons induced endogenous MECP2
protein (Figure 4F), whereas PUM1 overexpression reduced
MECP2 protein levels (Figure 4G). Multiple attempts at PUM1
knockdown for 5 days with shRNAs or siRNAs in hESCs were
compromised by cell morphology and proliferation changes
(data not shown). Taken together with the reporter studies, these
results show that PUM1 controls endogenous MECP2, consis-
tent with its ability to destabilize the long mRNA isoform.
PUM1 Interacts and Colocalizes with MECP2 in hESCs
To test the association of PUM1 with endogenous MECP2
mRNA in hESCs, we performed RNA immunoprecipitation (RIP)
assays using PUM1 antibody. RIP followed by qRT-PCR re-
vealed that both total and long isoform MECP2 transcripts
were bound by PUM1 protein in hESC extracts (Figure 5A). The
known PUM1 targets E2F3 and p27 also were associated with
PUM1 in our conditions. In contrast, neither 18S rRNA nor
GAPDH mRNA was detected with PUM1 antibody, indicating
the specificity of PUM1/RNA interactions.
We confirmed colocalization in hESCs of endogenousMECP2
transcripts with PUM1 protein by ImmunoRNA- fluorescence
in situ hybridization (FISH) (Figures 5B–5G). One RNA probe
set detected total MECP2 transcripts by RNA-FISH and a sec-
ond set detected the long isoform. As expected, significantly
more puncta corresponding to the total fraction (Figure 5B, red
puncta) were observed than puncta specific for the long isoform
only (Figure 5B, green puncta). Many RBPs, including PUM1, can
promote the assembly of target mRNAs into RNA granules
(Parker and Sheth, 2007; Van Etten et al., 2012). The immu-
noRNA-FISH signals showed PUM1 in green foci that were pre-
dominantly outside the nuclei, and the total fraction of MECP2
transcripts (short and long isoforms) was present in defined
red focal structures (Figure 5C). A proportion of MECP2 tran-
script puncta colocalized with PUM1 in all three dimensions,
as measured in the acquired confocal z stacks (Figures 5C
and 5D). Interestingly, probes that detect only the long isoform
had significantly increased puncta colocalization with PUM1
foci (Figures 5D and 5E). PUM1 knockdown for 2 days using
two independent siRNAs demonstrated the specificity of the
antibody (Figure 5F), and a non-specific control RNA hybridiza-
tion did not produce puncta (Figure 5G). These results confirm
that the long MECP2 isoform preferentially colocalizes with
PUM1, consistent with the presence of the PBE2 site only in
this isoform. Overall, PUM1 colocalization with MECP2 mRNA
is compatible with an in vivo interaction with the long MECP2
isoform in hESCs, and it agrees with the RIP assay findings.
MECP2-null iPSC-derivedneuronsdisplay alteredmorphology
consisting of reduced dendritic length, arborization complexity,
and soma size (Cheung et al., 2011; Li et al., 2013). To test
whether the decrease in MECP2 protein levels in neurons
elicited by PUM1 overexpression would recapitulate the typical
abnormal phenotype, we performed morphological measure-
ments on these neurons. To that end, we overexpressed PUM1
(or GFP as the negative control) in neurons and measured
dendrite complexity, length, and soma size (Figure S5A). As
expected, PUM1 overexpression in neurons induced similar
morphological changes as those observed in MECP2-null726 Cell Reports 17, 720–734, October 11, 2016iPSC-derived neurons, with impaired dendritic branching as
measured by Sholl analysis, shorter dendrites, and smaller
soma sizes (Figures S5B–S5F).
miR-200a and 302c Destabilize MECP2 Independently
of PUM1 in hESCs
Having firmly established that PUM1 regulates MECP2 expres-
sion, we next sought to explore the underlying mechanisms.
PUM1 can facilitate access of miRNAs to their seed sequences
by alleviating high-energy secondary structures in the 30 UTR
of target mRNAs (Kedde et al., 2010; Miles et al., 2012). In silico
secondary structure prediction suggested that very stable sec-
ondary structures surround PBE2 (Figure S6A). To investigate
whether PUM1 acts in cooperation with miRNAs to reduce
abundance of the long MECP2 transcript in hESCs, we used
TargetScan (http://www.targetscan.org) to predict potential
miRNA-binding sites surrounding PBE2. hsa-miR-200a and
hsa-miR-302c were selected as candidates for further analysis,
since they are highly expressed in hESCs and repressed upon
differentiation (Judson et al., 2009; Peng et al., 2012). As noted
above, the luciferase reporter fragments containing the deletion
or mutation of the PBE2 element did not completely reverse
the luciferase activity in hESCs back to basal levels (pLUC-
GAPDH), indicating that other repressing elements were present
near PBE2.
To investigate the possible contribution of miR-200a and miR-
302c in MECP2 repression, we co-transfected mimic-miRNA
molecules corresponding to the endogenous miRNAs together
with the luciferase reporter vector containing PBE2 and the pre-
dicted miRNA-binding sites. Both mimic-miRNAs independently
reduced reporter activity in 293T cells, and the reductionwas lost
using a mimic-miRNA control that had no complementarity with
any human miRNA and after site-directed mutagenesis of the
seed sequences of each miRNA (Figure 6A).
To evaluate whether PUM1 facilitates miR-dependent repres-
sion of MECP2, we co-transfected the mimic-miRNAs with
the luciferase reporters containing the mutation or deletion of
PBE2. Reduced reporter activity elicited by each miRNA was
more pronounced when the PBE was intact, but reporter activity
generally persisted without a functional PBE (Figure 6B, black
bars). This result suggests that PUM1 binding at PBE2 has
minimal impact on miRNA function. To further test whether
PUM1 cooperates with the miRNAs to reduce reporter activity,
we overexpressed PUM1 and the miRNAs in 293T cells. Indeed,
PUM1 overexpression alone reduced reporter activity to 0.5
relative light units (RLU), which was reverted back to 1.0 as
expected in PBE2 mutants (Figure 6B, orange bars). The role
of the miRNAs was shown by the further reduction in reporter
activity to 0.3 RLU by co-transfection of the mimic-miRNAs.
Moreover, the mimic-miRNAs could still repress the reporter
activity to 0.5 RLU even when the overexpressed PUM1 could
not bind to the PBE2 in the deletion or mutant reporters. These
results indicate that the miRNAs and PUM1 act independently
but have a combinatorial repressive effect on the long isoform
of MECP2 mRNA.
To complement this analysis, we investigated the effect of
the miRNAs on endogenous MECP2 in hESCs using two inde-
pendent approaches. First, we inhibited each of the miRNAs in
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Figure 4. PUM1 Destabilizes MECP2 Transcripts
(A) Schematic representation shows the two PBEs present in the 30 UTR of MECP2.
(B) Luciferase assay in 293T cells. The inset displays changes in PUM1 protein levels after overexpression (n = 10–16).
(C) qRT-PCR shows the effect of PUM1 overexpression or knockdown on the half-life of the reporter plasmid containing PBE2 (n = 3).
(D) Top: Schematic representation shows PBE2 and deletion (blue triangle) or mutation (green line) clones generated by site-directed mutagenesis. Bottom:
Luciferase assay of reporter vectors containing WT or mutant versions of PBE2 after PUM1 overexpression or knockdown is shown. Data are plotted relative to
GFP or siRNA scrambled (scr) controls for each reporter condition (n = 3).
(legend continued on next page)
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hESCs by transfection of anti-miRNAs with reverse complemen-
tarity to the endogenousmiRNAs to bind and inhibit their activity.
In agreement with the luciferase reporter experiments, we
observed a significant increase in the steady-state levels of the
long isoform after inhibition of each miRNA (Figure 6C), although
no change was observed in the total fraction. Interestingly, the
increase in the levels of the long isoform was accompanied by
a significant increase in the levels of the MECP2-E1 transcript
isoform, but not MECP2-E2. In addition, we transfected hESCs
with target protector RNAs for both miRNA sites. These are
long synthetic RNAs with reverse complementarity to the spe-
cific miRNA seed sites and surrounding sequence in the
MECP2 transcript. They impair the ability of the endogenous
miRNAs to bind MECP2 transcripts, and, due to their length,
they are not substrates for RISC-dependent miRNA-guided
RNA degradation. Similar to the anti-miRNAs, both target pro-
tector RNAs independently increased levels of the long MECP2
isoform, and the miRNA-200a protector increased levels of the
MECP2-E1 isoform (Figure 6D). These data suggest that the
MECP2-E1 isoform is composed of transcripts containing
the long 30 UTR. Taken together, these results confirm that
MECP2 mRNA levels are reduced in hESCs by a combinatorial
effect of PUM1 and miR-200a and miR-302c.
Translational Regulation ofMECP2 Is Mediated by a
U-Rich Element in the 30 UTR
The post-transcriptional regulation of MECP2 in cells also is
controlled at the translational level. To evaluate translational
regulation of endogenous MECP2 transcripts, we performed
polysome-profiling assays in hESCs and neurons, and we quan-
tified the total fraction ofMECP2mRNA in the different polysome
fractions (Figure S7A). The majority of MECP2 transcripts were
present in the free-monosome fraction in hESCs, whereas in
neurons most MECP2 transcripts were detected in the heavy-
polysome fractions (Figure 7A). These results confirm that
endogenous MECP2 transcripts are translationally silenced in
hESCs, given that they are not engaged in active translation.
As differentiation progressed, two effects were observed: the
long transcript isoform accumulated to greater levels and the
corresponding association of MECP2 transcripts with poly-
somes increased, resulting in MECP2 protein synthesis and
accumulation in neurons.
Sequence inspection revealed a conserved U-rich sequence
at 102–127 immediately upstream of the first PA site of MECP2
30 UTR (Figure S7B). To evaluate its role, we mutated every sec-
ond T into a C (Figures 7B and S7B). Indeed, this mutation
(pLUC-1–149_T > C) completely abolished the reduction in
translation seen for the WT sequence in hESCs as well as the
enhancement of translation in neurons when compared to basal
levels in the control pLUC-GAPDH (Figure 7B), whereas there
was no change in reporter mRNA levels. These results demon-
strate that the U-rich element was required for translational regu-(E) Luciferase assay in hESCs using reporter plasmids containing WT or mutant
(F and G) Western blot shows increase or decrease of MECP2 protein levels after
bars, SEM; *p < 0.05, **p < 0.01, and ****p < 0.001 (ANOVA, Bonferroni post-test fo
See also Figure S4.
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Given that MECP2 protein is poorly detected in hESCs, we infer
that the element prevents translation of both the small and large
transcript isoforms in hESCs. In neurons, translation is enhanced
by the same element and should function on both isoforms, un-
less the short isoform is a completely abortive transcript that fails
to be translated in neurons.
Translation of MECP2 Transcripts Is Regulated by the
RBPs TIA1 and HuC
The fact that the same U-rich element induces opposite out-
comes for reporter protein levels in hESCs and neurons suggests
that cell-type-specific factors regulate the translation of MECP2.
Two proteins identified in our affinity purification experiments
were the translational regulators TIA1 and HuC. To assess
whether translational repression of MECP2 transcripts is medi-
ated by TIA1, we first tested the luciferase activity of our reporter
constructs after TIA1 knockdown in hESCs (Figure 7C). Interest-
ingly, the luciferase activity of the construct containing the WT
1–149 region was increased to that of basal levels after TIA1
knockdown using two independent siRNAs in the hESCs,
whereas no changes were observed in the T > Cmutant reporter
in hESCs (Figure 7C) or 293T cells (Figure S7C). Importantly, we
confirmed that endogenous MECP2 protein levels were signifi-
cantly increased in hESCs after the reduction of TIA1 by the
siRNAs (Figures 7D and S7D). Additionally, we demonstrated
that TIA1 protein levels were significantly lower in neurons
compared to hESCs, which could in part explain a lower effect
of TIA1-mediated translation repression of MECP2 in neurons
(Figure S7E). We also demonstrated that TIA1 interacted with
MECP2 transcripts. ImmunoRNA-FISH showed that TIA1 gran-
ules partially colocalized with both MECP2 transcript isoforms
at similar frequencies (Figures 7E and 7F). Knockdown of TIA1
with two independent siRNAs demonstrated the specificity of
the antibody (Figure 7G). In addition, RIP followed by qRT-PCR
showed that both total and long MECP2 transcripts associated
with TIA1 protein in hESCs and that the association was less
prominent in neurons (Figure S7F).
To investigate the roles of HuC protein in translation enhance-
ment of MECP2 protein in neurons, we repeated the luciferase
reporter assays after knockdown of HuC. Indeed, the increased
reporter activity induced by the 1–149 fragment was lost after
HuC repression by siRNAs in neurons (Figure 7H). Interestingly,
overexpression of HuC, but not HuD, induced the reporter
activity of pLUC-1–149 in 293T cells (Figure S7G). Moreover,
we confirmed the positive regulation of endogenous neuronal
MECP2 protein levels after HuC overexpression (Figures 7I, 7J,
and S7H). Finally, we demonstrated the association between
HuC protein and MECP2 transcripts by RIP qRT-PCR in neuron
extracts (Figure S7I). Taken together, these results demonstrate
that in hESCsMECP2 transcripts are directly bound and transla-
tionally repressed by TIA1. Upon differentiation to neurons, TIA1PBE2 (n = 3) is shown.
knockdown or overexpression of PUM1 in neurons, respectively (n = 3). Error
r luciferase assay and qRT-PCRs, or SEM for western blots by Student’s t test).
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Figure 5. PUM1 Directly Associates with MECP2 Transcripts
(A) RIP-qRT-PCR using PUM1 antibody and isotype IgG control in hESCs extracts shows the association between PUM1 and MECP2 transcripts (n = 3). Error
bars, SEM; *p < 0.05 and **p < 0.01 (ANOVA, Bonferroni post-test).
(B–D) Confocal imaging of RNA-FISH using probes against MECP2 total (C) or long transcripts (D) and PUM1 immunostaining, counterstained with
Hoechst33258. Boxed areas show higher magnification. Arrowheads, colocalization puncta.
(E) Quantification of PUM1/MECP2 colocalization is shown. Scale bars, 10 mm (B, low magnification), 2.5 mm (B–D, high magnification), 5 mm (C, D, F, and G, low
magnification). Error bars, SEM; n = 60 cells each; **p < 0.01 (Student’s t test).
(F) PUM1 antibody specificity is demonstrated by confocal imaging of immunostained hESC after knockdowns.
(G) Negative control for RNA-FISH using a non-specific DapB probe is shown.
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Figure 6. miRNAs 200a and 302c Destabilize MECP2 Long Transcripts Independent of PUM1
(A) Schematic representation of luciferase reporter plasmids harboring the WT (pLUC-4,265–5,677) or mutant binding sites for miRNAs 200a (pLUC-4,265–5,677
200a mt) and 302c (pLUC-4,265–5,677 302c mt) (top). Red and blue lines represent the presence of the WT binding sites for miRNAs 200a or 302c, respectively,
and orange line represents PBE2. Luciferase assay in 293T cells using the plasmids shown above and overexpression of eachmimic-miRNA (bottom) are shown.
Results are plotted relative to mimic-miRNA control (negative control, n = 3).
(B) Luciferase assay in 293T cells using the plasmid harboring the PBE2WT (left), PBE2mut (middle), or PBE2 del (right) and overexpression of eachmimic-miRNA
and PUM1 (n = 3) are shown.
(C) qRT-PCR in hESCs after repression of each miRNA using anti-miRs (n = 3) is shown.
(D) qRT-PCR in hESCs after transfection of target protector synthetic RNAs specific for theMECP2 transcript seed sites for miRNAs-200a and -302c. Error bars,
SEM; *p < 0.05, **p < 0.01, ***p < 0.005, and ****p < 0.001 (ANOVA, Bonferroni post-test). See also Figure S6.
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levels and its association with MECP2 transcripts are reduced,
while HuC contemporaneously increases, which together lead
to a substantial increase in the translation of MEPC2.
DISCUSSION
In the present study, we identified key post-transcriptional regu-
lators ofMECP2 protein levels during human neurodevelopment.
Our data revealed that RBPs and miRNAs interact with se-
quences in the conserved 30 UTR ofMECP2 transcript to control
mRNA stability and translational efficiency. First, the long 30 UTR
isoform of MECP2 mRNA is destabilized in hESCs via the
concerted action of PUM1 and two pluripotency-associated
miRNAs. Second, the translational efficiency of all MECP2 tran-
scripts is repressed in hESCs via interactions of the 30 UTR with
TIA1. Together these pathways reduce the half-life of MECP2
transcripts and minimize ribosome engagement, thereby pre-
venting MECP2 protein accumulation in hESCs. We demon-
strated that overexpression ofMECP2 E1 protein in the absence
of the 30 UTR in hESCs affects stem cell proliferation. Upon dif-
ferentiation into neurons, a switch occurs to post-transcription-
ally upregulate MECP2. MECP2 transcripts are stabilized by
the absence of the pluripotency-specific stem cell miRNAs,
and the neuron-specific protein HuC outcompetes TIA1 in order
to enhance ribosome engagement. The overall effect is that,
although active transcription rates for MECP2 are similar in
hESCs and neurons, post-transcriptional mechanisms ensure
that MECP2 protein accumulates to high levels only in neurons.
Still, the precise role of PUM1 in neurons is unclear. Further
analysis is required to fully test the functional significance of
the entire 3’ UTR sequence.
MECP2 mRNA Destabilization by PUM1 and miRNAs in
hESCs
We found that active nascent transcription of MECP2 is essen-
tially the same between hESCs and neurons. Tellingly, hESCs
accumulate primarily the short 30 UTR isoform, while the level
of the long 30 UTR isoform progressively increases during neuro-
development. The most functionally significant region of the 30
UTR involved in mRNA stability was mapped to the conserved
PBE2-binding site and its interactions with PUM1. Moreover,
the nearby seed sequences for the pluripotency-associated
miRNAs hsa-miR-200a and hsa-miR-302c act in concert with,
but do not require, PUM1 for this function. Our results implicateFigure 7. Translation of MECP2 Transcripts Is Silenced in hESCs and E
(A) qRT-PCR from polysome profiles of total RNA from hESCs and neurons. mRNA
ACTB mRNA levels were used as a positive control of active translation in both c
(B) Luciferase activity and mRNA levels of hESCs and neurons transfected with
(n = 3) are shown.
(C) Luciferase activity in hESCs using plasmids harboring WT or mutant U-rich e
(ANOVA, Bonferroni post-test).
(D) Western blot and quantification of MECP2 protein levels after knockdown of
(E and F) Confocal imaging (E) and quantification (F) of RNA-FISH using probes for
(G) TIA1 antibody specificity demonstrated by confocal imaging of immunostain
(E, high magnification), and 10 mm (G, low magnification).
(H) Luciferase assay in neurons using plasmids harboring WT or mutant U-rich e
(I and J) Western blot (I) and quantification (J) of MECP2 protein levels after HuC o
***p < 0.005 (Student’s t test). See also Figure S7.
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miR-302c in hESCs. These miRNAs are known to regulate genes
via mRNA decay, and they have been used to promote somatic
cell reprogramming (Judson et al., 2009), which should downre-
gulate MECP2 in the resulting iPSCs.
We found that PUM1 overexpression reduced MECP2 protein
levels in hESC-derived neurons, and this was accompanied
by reduced dendrite complexity and smaller soma size. PUM1
regulates ATAXIN1 mRNA levels in the mouse brain causing a
Spinocerebellar ataxia type 1 (SCA1)-like neurodegeneration
phenotype (Gennarino et al., 2015). Our data expand on the
importance of PUM1 as a key post-transcriptional regulator of
neurodevelopment and proper maintenance of neuronal
morphology, and they implicate MECP2 as a PUM1 target. Its
role in degrading the MECP2 long 30 UTR in hESCs supports
a different viewpoint for the use of APA sites in post-transcrip-
tional control of neuronal genes. Indeed, a general observation
is that many transcripts associated with neuronal functions
undergo 30 UTR lengthening during neurodevelopment (Miura
et al., 2013). Our results suggest that this lengthening is not
necessarily related to tissue-specific changes in PA site usage,
but instead these long 30 UTRs may be constitutively tran-
scribed and become targets for mRNA degradation in precursor
cell types.
MECP2 Translational Control by TIA1 and HuC RBPs
We elucidated a previously unappreciated translational regula-
tory mechanism controlling MECP2 protein levels during neuro-
development. Our polysome association and western blot data
suggest that translation ofMECP2 dramatically increases during
differentiation from hESCs to neurons. The most functionally sig-
nificant region of the 30 UTR involved in translational efficiency
was aU-rich sequence element immediately upstreamof the first
PA site. This element is present in all APAMECP2 transcript var-
iants, and it mediates the switch from translational repression in
hESCs to translation enhancement in neurons. The ability of the
same sequence element to confer such strikingly opposite ef-
fects on translation is dependent on TIA1 and HuC, which have
been reported to compete for the same U-rich element in human
cells (Zhu et al., 2006). We found that TIA1 is responsible for
translational repression ofMECP2 transcripts in hESCs, consis-
tent with the known function of TIA1 that segregates targeted
mRNAs from actively translating polysomes (Lo´pez de Silanes
et al., 2005). Moreover, an interesting feature of translationalnhanced in Neurons
levels were normalized by spike-in RNAs and plotted as a percentage of total.
ells (n = 3). Error bars, SEM.
plasmids harboring WT or mutant U-rich element present in the 1–149 region
lement and knockdown of TIA1 (n = 3) are shown. Error bars, SEM; *p < 0.05
TIA1 in hESCs (n = 3) are shown. Error bars, SEM; *p < 0.05 (Student’s t test).
MECP2 total and long transcripts and TIA1 immunostaining in hESC are shown.
ed hESC after knockdowns. Scale bars, 5 mm (E, low magnification), 2.5 mm
lement and HuC knockdowns are shown.
verexpression in hESC-derived neurons (n = 3). Error bars, SEM; *p < 0.05 and
silencing promoted by TIA1 is its association with translation
initiation factors, which can promptly re-engage translation of
the targeted mRNAs upon proper environmental cues (Kedersha
et al., 2002). Thus, it is likely that TIA1 keeps the pool of develop-
mentally associated transcripts, such as MECP2, translationally
silenced in pluripotent cells and early stages of development. We
also found that translation enhancement ofMECP2 in neurons is
dependent on HuC protein, potentially enhancing translation of
both short and long MECP2 transcript isoforms.
Our findings provide extensive insight into the post-transcrip-
tional regulation ofMECP2 in hESCs and neurons, and they have
implications for neurodevelopment. Many mutations have been
reported in the long 30 UTR (Coutinho et al., 2007), and, conceiv-
ably, these may affect the post-transcriptional circuitry and
contribute to abnormal neuronal function. Thus, it may prove crit-
ical for gene therapy to incorporate functional 30 UTR motifs into
gene transfer vectors to deliver physiological levels of MECP2 in
affected cell types.
EXPERIMENTAL PROCEDURES
Cell Culture and Cortical Neuronal Differentiation
H9 hESCs obtained from the National Stem Cell Bank (WiCell) and Rett syn-
drome iPSCs (Cheung et al., 2011) were cultured withmTeSR1 culturemedium
(STEMCELL Technologies) on Becton Dickinson hESC-qualified matrigel.
Pluripotent stem cell work was approved by the Canadian Institutes of Health
Research Stem Cell Oversight Committee and The Hospital for Sick Children
Research Ethics Board. An embryoid body (EB)-based method was used for
neuronal induction of NPCs (Brennand et al., 2011). See the Supplemental
Experimental Procedures for details. The 293T cells were cultured in DMEM
with 10% fetal bovine serum (Invitrogen).
Total RNA Extraction, qRT-PCR, and mRNA Half-Life Assay
Total RNA was processed using RNeasy Plus kit (QIAGEN) and SuperScript III
reverse transcriptase (Invitrogen) with random hexamer primers. For the
qRT-PCR, we used SYBR Select PCR Master Mix (Applied Biosystems) with
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) or 18S as internal
amplification controls. Fold changes were calculated by the 2(DDCt) method.
For half-life assays, 10 mg/mL actinomycin D (Sigma-Aldrich) was added to
hESCs, neurons, or 293T cells. RNAswere isolated at the indicated time points
for qRT-PCR.
Nascent Transcription Assay
The hESCs and 3-week-old neurons were incubated with 0.5 mM EU (Invitro-
gen) for 30 min. Total RNA was extracted and processed using Click-iT
Nascent RNA Capture kit (Invitrogen) according to the manufacturer’s instruc-
tions. The captured RNAs were used as a template for cDNA synthesis fol-
lowed by qRT-PCR.
miRNA Overexpression and Knockdown
For miRNA overexpression, 293T cells or hESCs were grown overnight and
transfected with mirVana mimics-miRNA (Invitrogen) as follows: hsa-miR-
200a-3p (MC10991), hsa-miR-302c-5p (MC10531), and mimic negative con-
trol 1. For miRNA knockdown, cell were transfected with anti-miR-200a-3p
(MH 105991), anti-miR-302c-5p (MH 10531), or anti-miR-Mimic control 1
(Invitrogen). All transfections were carried out using Lipofectamine RNAiMAX
(Invitrogen) and RNA was collected after 48 hr.
RIP qRT-PCR
The hESCs were seeded in two 10-cm dishes and grown overnight. Cells were
then washed in ice-cold PBS. RIPs were carried out using EZ-Magna RIP-RNA
Immunoprecipitation kit (Millipore) according to the manufacturer’s instruc-
tions. 5 mg of antibodies anti-TIA1, anti-PUM1, and anti-HuCwere used per re-
action (see the Supplemental Experimental Procedures); 5 mg of each isotypeIgG antibody was used as a negative control. Target transcripts were detected
by qRT-PCR and plotted as percentage of input.
RNA-FISH
RNA-FISH was performed using RNAscope kit (Advanced Cell Diagnostics).
Probes targeting the full length of MECP2 coding sequence (CDS) or the
long 30 UTR sequence of MECP2 mRNA (5,000–8,554 nt counted from first
nucleotide of the 30 UTR) and negative control DapB were designed using
Advanced Cell Diagnostics’s (ACD’s) proprietary algorithm. In brief, hESCs
cultured for 5 days were fixed with 4% paraformaldehyde (PFA) and dehy-
drated with ethanol, followed by cell pretreatment, probe hybridization, and
signal amplification according to the manufacturer’s instructions. Cells were
then immunostained for PUM1 or TIA1. The z stacks of images of random re-
gions were taken with an optical slice thickness of 0.1 mm, using a 603 objec-
tive on an Olympus IX81 fluorescence microscope equipped with a Hama-
matsu C9100-13 back-thinned electron multiplying charged coupled device
(EM-CCD) camera and Okogawa CSU X1 spinning-disk confocal scan head.
For quantification, mRNA foci were identified as bright punctate dots present
in the nucleus and/or cytoplasm, and about 30–60 cells were quantified in each
condition. The mRNA foci that were fully or partially overlapped with PUM1-
positive or TIA1-positive granules from z stacked images were counted.
Statistical Analysis
All results presented are the average of at least three experiments expressed
as mean ± SEM. Statistical significance was determined by two-way ANOVA
with Bonferroni post hoc analyses or Student’s unpaired t test, as indicated
in the figure legends, using Prism 5 (GraphPad). Probabilities of p < 0.05
were considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.09.049.
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